CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Denali Therapeutics Inc.

DNLI
$3.33BMid Cap

Next catalyst

Phase 2December 2026

DNL593

Frontotemporal Dementia

Get an email about DNLI's next catalysts

Track Denali Therapeutics (DNLI) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.

Plus 1 more upcoming event in our data (Phase 2 readout).See the timeline

Catalyst Timeline

2 upcoming, 1 past

Phase 2Next

DNL593 Phase 2 Est. Readout

December 2026~DNL59385

Primary completion for DNL593 trial (NCT05262023) in Frontotemporal Dementia

Source
Phase 2

BIIB122 Phase 2 Est. Readout

March 2027~BIIB12250

Primary completion for BIIB122 trial (NCT06602193) in Parkinson Disease

Source

Market Overview

Stock performance and key metrics

NASDAQBiological Products, (No Diagnostic Substances)πŸ‡ΊπŸ‡ΈNorth AmericaSOUTH SAN FRANCISCO517 employees
Drug Pipeline

Frequently asked questions

What is in Denali Therapeutics Inc.'s drug pipeline?β†’

CatalystAlert tracks 7 drug candidates in Denali Therapeutics Inc.'s (DNLI) pipeline across Phase 3, Phase 2. Its lead program is DNL343 (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.

When is Denali Therapeutics Inc.'s next FDA catalyst?β†’

Denali Therapeutics Inc.'s (DNLI) next tracked catalyst is a Phase 2 readout expected December 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.

How do I track DNLI biotech catalysts?β†’

Add DNLI to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow Denali Therapeutics Inc.'s live catalyst calendar, drug pipeline and clinical-trial timeline on this page β€” sourced from ClinicalTrials.gov, FDA and SEC filings.

Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply